Scientists at St. Jude Children’s Research Hospital have found a way to use a bacterium’s own drug resistance mechanisms against itself, presenting a potentially safer and more effective way to treat certain antibiotic-resistant infections.
The Centers for Disease Control and Prevention estimated in 2023 that 14% of Americans—more than 35 million people—suffer from chronic kidney disease.
Gene expression governs whether neuroblastoma tumor cells exist in either the adrenergic (differentiated and sensitive to treatment) or mesenchymal (less differentiated and therapy-resistant) cell state.
There are about 70 million baby boomers in the United States, many now over age 65.
Researchers in the University of Tennessee, Knoxville’s Tickle College of Engineering are using artificial intelligence and machine learning to provide treatment plans to breast cancer patients more quickly by analyzing pathology reports and other clinical records to determine how much breast cancer is in the body.
At the University of Tennessee, Knoxville, researchers are harnessing the power of artificial intelligence to deliver practical solutions to real-world challenges—from enabling more precise surgeries and quicker scanning for cancer to preparing students and workers for success in an increasingly AI-driven future.
The National Institute of Neurological Disorders and Stroke has awarded $2.18 million to two researchers at the University of Tennessee Health Science Center for a project focused on a new drug treatment to protect the brain after a stroke.
The National Institute of Deafness and Other Communication Disorders has awarded $1.9 million to John Boughter, PhD, professor in the Department of Anatomy and Neurobiology and co-director of the Neuroscience Institute at the University of Tennessee Health Science Center (UTHSC), to study the brain circuitry involved in processing novel tastes and foods. Max Fletcher, PhD,… Read More
